Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$110.33
+0.26%
Mkt Cap $6.81B
Analyst Ratings
Buy
13
Hold
1
Sell
0
Price Target (16 analysts)
$116.75
Range $108.00 – $121.00
Implied Upside
+5.8%
Consensus $116.75 vs current $110.33